Mirabella Financial Services LLP Acquires New Position in Ralliant Corporation $RAL

Mirabella Financial Services LLP acquired a new stake in Ralliant Corporation (NYSE:RAL) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor acquired 24,700 shares of the company’s stock, valued at approximately $1,080,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Westfuller Advisors LLC purchased a new position in shares of Ralliant during the third quarter worth approximately $26,000. Palisade Asset Management LLC purchased a new stake in shares of Ralliant in the third quarter valued at approximately $26,000. Manchester Capital Management LLC bought a new position in Ralliant in the second quarter worth approximately $29,000. UMB Bank n.a. bought a new position in Ralliant in the third quarter worth approximately $29,000. Finally, BOKF NA purchased a new position in Ralliant during the 3rd quarter worth $29,000.

Insider Activity at Ralliant

In other news, Director Anelise Angelino Sacks purchased 2,000 shares of the company’s stock in a transaction on Monday, February 9th. The shares were acquired at an average price of $41.25 per share, for a total transaction of $82,500.00. Following the purchase, the director owned 5,403 shares in the company, valued at $222,873.75. This trade represents a 58.77% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Amir A. Kazmi acquired 2,545 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was purchased at an average cost of $39.27 per share, for a total transaction of $99,942.15. Following the completion of the acquisition, the senior vice president directly owned 39,699 shares of the company’s stock, valued at approximately $1,558,979.73. This trade represents a 6.85% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 8,145 shares of company stock worth $332,233 in the last quarter.

Ralliant Trading Down 0.4%

Shares of NYSE:RAL opened at $42.49 on Friday. The business’s 50-day moving average is $47.52 and its 200 day moving average is $46.71. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. Ralliant Corporation has a 1 year low of $37.27 and a 1 year high of $57.02. The firm has a market capitalization of $4.75 billion and a P/E ratio of 21.68.

Ralliant (NYSE:RAL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to analysts’ expectations of $543.04 million. The firm’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be paid a $0.05 dividend. The ex-dividend date is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Ralliant’s dividend payout ratio (DPR) is 10.20%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Morgan Stanley reaffirmed an “overweight” rating and set a $45.00 target price on shares of Ralliant in a research report on Friday, February 6th. Vertical Research raised Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target on the stock in a research report on Friday, February 6th. Barclays cut their price target on Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research note on Monday, February 9th. Oppenheimer lowered their price objective on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Finally, Citigroup dropped their target price on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $50.50.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.